Madrigal Pharmaceuticals
MDGL
MDGL
205 hedge funds and large institutions have $2.54B invested in Madrigal Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 89 increasing their positions, 54 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 208 → 205 (-3)
26% less capital invested
Capital invested by funds: $3.43B → $2.54B (-$890M)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Holders
205
Holding in Top 10
6
Calls
$225M
Puts
$111M
Top Buyers
| 1 | +$228M | |
| 2 | +$35.1M | |
| 3 | +$29.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$28.2M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$25.3M |
Top Sellers
| 1 | -$62M | |
| 2 | -$26M | |
| 3 | -$19.6M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$15.7M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$11.6M |